APA (7th ed.) Citation

Zakumumpa, H., Kitutu, F. E., Ndagije, H. B., Diana, N., Ssanyu, J. N., & Kiguba, R. (2021). Provider perspectives on the acceptability and tolerability of dolutegravir-based anti-retroviral therapy after national roll-out in Uganda: A qualitative study. BMC Infectious Diseases, 21(1), 1. https://doi.org/10.1186/s12879-021-06933-8

Chicago Style (17th ed.) Citation

Zakumumpa, Henry, Freddy Eric Kitutu, Helen Byomire Ndagije, Nakitto-Kesi Diana, Jacquellyn Nambi Ssanyu, and Ronald Kiguba. "Provider Perspectives on the Acceptability and Tolerability of Dolutegravir-based Anti-retroviral Therapy After National Roll-out in Uganda: A Qualitative Study." BMC Infectious Diseases 21, no. 1 (2021): 1. https://doi.org/10.1186/s12879-021-06933-8.

MLA (9th ed.) Citation

Zakumumpa, Henry, et al. "Provider Perspectives on the Acceptability and Tolerability of Dolutegravir-based Anti-retroviral Therapy After National Roll-out in Uganda: A Qualitative Study." BMC Infectious Diseases, vol. 21, no. 1, 2021, p. 1, https://doi.org/10.1186/s12879-021-06933-8.